验证数据展示
经过测试的应用
Positive IHC detected in | mouse testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
Biotin-11059 targets IL-13RA2 in IHC applications and shows reactivity with human, mouse, rat samples.
经测试应用 | IHC Application Description |
经测试反应性 | human, mouse, rat |
免疫原 | IL-13RA2 fusion protein Ag1534 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | interleukin 13 receptor, alpha 2 |
别名 | IL13RA2, IL 13R subunit alpha 2, IL 13R alpha 2, IL 13R, IL 13 receptor subunit alpha 2 |
计算分子量 | 380 aa, 44 kDa |
观测分子量 | 65 kDa |
GenBank蛋白编号 | BC020739 |
基因名称 | IL13RA2 |
Gene ID (NCBI) | 3598 |
RRID | AB_3672369 |
偶联类型 | Biotin |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q14627 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
IL13RA2, also named as IL13R and CD213a2, belongs to the type I cytokine receptor family. It binds as a monomer with high affinity to interleukin-13 (IL13), but not to interleukin-4 (IL4). IL13RA2 lacks the cytoplasmic domain for signaling, indicating that it acts as a decoy receptor. IL13RA2 gene polymorphisms have been associated with systemic sclerosis (PMID: 16981293). Overexpression of IL13RA2 gene has been reported in several types of cancer, including melanoma, lung cancer, and brain tumor, which makes it a potential immunotherapeutic target (PMID: 19895199; 24970476; 24021875).
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for Biotin IL-13RA2 antibody Biotin-11059 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |